Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover
about
Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeuticsProteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclastsExpression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system.Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesityIdentification of a non-purple tartrate-resistant acid phosphatase: an evolutionary link to Ser/Thr protein phosphatases?Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice.Osteoclasts: more than 'bone eaters'.Increased tartrate-resistant Acid phosphatase expression in osteoblasts and osteocytes in experimental osteoporosis in rats.Biology of tartrate-resistant acid phosphatase.Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes.Polyphosphate-mediated inhibition of tartrate-resistant acid phosphatase and suppression of bone resorption of osteoclasts.Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation.Imaging an adapted dentoalveolar complexThe Inhibitory Effect of Alisol A 24-Acetate from Alisma canaliculatum on OsteoclastogenesisBromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways.Towards a better understanding and new therapeutics of osteopetrosis.Mechanisms of osteoclast-dependent bone formation.Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directlyInteraction of staphylococci with bone.Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osOptimization of the tartrate-resistant acid phosphatase detection by histochemical method.Ovine cortical osteoblasts outperform bone marrow cells in an ectopic bone assay.Markers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs.Diethylalkylsulfonamido(4-methoxyphenyl)methyl)phosphonate/phosphonic acid derivatives act as acid phosphatase inhibitors: synthesis accompanied by experimental and molecular modeling assessments.Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors.Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis.Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.Disruption of the transcription factor RBP-J results in osteopenia attributable to attenuated osteoclast differentiation.Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNFα therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabEffects of Bisphosphonate Administration on Cleft Bone Graft in a Rat Model.Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation.Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female mice.Increased early inflammatory response and osteoclastic activity in gingival tissues following conventional osseous resective surgery compared with the fibre retention technique: a pilot study.Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro.Analysis of distinct tartrate-resistant acid phosphatase promoter regions in transgenic mice.Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells.
P2860
Q27682112-E0E02C89-2927-40A7-B5E1-024B0BC114ACQ28254073-CA3EDA79-F7B4-4FBE-82D4-3F9C11F5D2E3Q31961220-1575F016-2D82-46D4-8210-249500708819Q33322517-97332CD3-4420-42D6-AC9E-22D477E2301DQ33366856-DF81DE41-0D1D-465A-A9C3-B8E3E77824B3Q33779245-68F26224-DEA9-4D6A-9F83-40713E20B10DQ33993757-8C45944E-9350-4B3B-A3E2-BE4300BC988EQ34105054-F2ADE6A8-EE02-409F-8B29-8160C9918644Q34244462-91BAD30A-0776-464C-8E8F-C6B66B1ACE9AQ34983640-68F6F4F3-A7DC-4C80-ACDB-92AC84CFC197Q35040991-840CF256-F1E3-403A-8F5A-209C2725896DQ35106502-4EF011CE-1506-449C-B1BA-76A226D6143DQ35910625-03874B2A-8023-437D-BA7D-CAEED1DC15DAQ35932306-2CFA62B4-4C97-4072-AB49-86F52B8F1B20Q36385001-014A343D-0FA3-42BB-99AE-4BAFF4D479AEQ37074250-968616A9-0013-49CF-A3A1-C6F64DBBF56BQ37414413-64BE2FC1-33F2-4BF8-8F4F-F29A73498443Q37432210-36731B83-A87C-46F7-BC2F-9D32A65C82D3Q37627430-6D325C98-3FB7-4983-9101-45700F57D903Q37643521-7C6279D9-A71E-4FC5-9B20-072F2480778FQ38314047-6E29DACB-3135-47A9-9F75-84592161FED4Q38337385-2981A48C-5534-4E3D-92B8-46B9B0279A71Q38640619-2AED03F0-8212-4A56-9399-AADECBEFEB1EQ39263532-7D59B912-47B6-4210-AFF9-743147E1EBD8Q39411610-45DEB447-91C2-481B-AF55-279DEED123E4Q39495372-4567782A-E118-4073-AB5F-E6015F60F783Q39817003-B14382CD-8D4B-43D5-B390-2D392C44D131Q41003979-B13C4DDA-CED1-455A-9439-C49DE43D241BQ42758410-F966BA8A-F1FC-48BC-A09D-2963131E140CQ45157422-BA55EC6A-D553-4484-8B4B-9AF4C0B4D2BDQ45325759-E9E105FE-8533-4B60-8B79-4CECA1780B53Q45832844-9ED6D12D-BA96-4232-B073-E7F8E1CC7E77Q47888617-A7667590-82A7-4931-842E-450C4850F425Q48006799-E1CA1524-B601-44D6-9BDD-6685299C3703Q50889329-5E1A1E0A-F123-4908-886D-638C78E406F4Q51242139-A590E5A1-A871-459D-80B2-C2B3BB2BF224Q51543957-725C4B4D-82F6-4079-B7D5-C1375B892066Q53109365-FB0E9A67-BF72-4A1B-97B8-6A90B5B04CDDQ53877342-2B6781CF-5D09-4D65-B1DA-8389DF40DD21Q54008160-4F13E060-7C75-4EA0-A9EF-09B5A765F340
P2860
Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover
description
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2000
@ast
im Jahr 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2000)
@en
wetenschappelijk artikel (gepubliceerd in 2000-01)
@nl
наукова стаття, опублікована в січні 2000
@uk
مقالة علمية (نشرت عام 2000)
@ar
name
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@ast
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@en
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@nl
type
label
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@ast
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@en
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@nl
prefLabel
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@ast
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@en
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@nl
P2093
P1476
Transgenic mice overexpressing ...... ncreased rate of bone turnover
@en
P2093
A I Cassady
M C Ostrowski
M R Forwood
P2860
P304
P356
10.1359/JBMR.2000.15.1.103
P407
P577
2000-01-01T00:00:00Z